Skip to main content

PLIVA 327 Pill - orange round, 8mm

Pill with imprint PLIVA 327 is Orange, Round and has been identified as Hydralazine Hydrochloride 25 mg. It is supplied by Teva Pharmaceuticals.

Hydralazine is used in the treatment of Hypertensive Emergency; High Blood Pressure; Heart Failure and belongs to the drug class vasodilators. Risk cannot be ruled out during pregnancy. Hydralazine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PLIVA 327

Hydralazine hydrochloride 25 mg PLIVA 327
Hydralazine hydrochloride 25 mg PLIVA 327
Hydralazine hydrochloride 25 mg PLIVA 327
Hydralazine hydrochloride 25 mg PLIVA 327 Front
Hydralazine hydrochloride 25 mg PLIVA 327 Back

Hydralazine Hydrochloride

Imprint
PLIVA 327
Strength
25 mg
Color
Orange
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Vasodilators
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals
National Drug Code (NDC)
50111-0327
Inactive Ingredients
lactose anhydrous, FD&C Yellow No. 6, microcrystalline cellulose, sodium starch glycolate type A potato, stearic acid

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.